Clinical Trial Update: Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab given concurrently with and after carbon-ion radiotherapy for locally advanced cervical adenocarcinoma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Gunma University | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING